Establishment of cell polarity by Par-1 kinase during Drosophila oogenesis: assessment of biochemically identified Par-1 substrates as targets in vivo
Establishment of cell polarity by Par-1 kinase during Drosophila oogenesis: assessment of biochemically identified Par-1 substrates as targets in vivo
批准号:
5331590
负责人:
Dr. Anne Ephrussi, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2001
资助国家:
德国
项目状态:
已结题
起止时间:
2000-12-31 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The gene par-1 encodes an evolutionarily conserved Ser/Thr kinase. Genetic data show that par-1 is required for the establishment of polarity in organisms as divergent as worms and flies. Although biochemical data suggest a function of the mammalian Par-1 homologue, MARK, in regulating cytoskeletal organisation by phosphorylating microtubule-associated proteins (MAPs), this property of the kinase is not sufficient to explain the polarity defects observed in the par-1 mutants. We use Drosophila oogenesis as a model to understand the mechanisms of cell polarization. par-1 is required several times for establishment and maintenance of cell polarity during oogenesis, but the mechanism by which Par-1 regulates cell polarity is not understood, as neither in C. elegans nor in Drosophila are Par-1 target proteins known. We will use "in vitro expression cloning" to identify cDNAs encoding proteins that are phosphorylated by Par-1. Pools of cDNAs will be transcribed and translated in vitro to be tested as substrates of the kinase. We will systematically screen the Drosophila genome for Par-1 targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamic regulation of mRNA transport and translation in the Drosophila germline
-
批准号:420693198
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Dr. Anne Ephrussi, Ph.D.
-
依托单位:
Tropomyosin 1 and End-binding protein 1 in mRNA transport
-
批准号:313646688
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Dr. Anne Ephrussi, Ph.D.
-
依托单位:
mRNP assembly and remodeling for transport and translational control in Drosophila
-
批准号:283135182
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Dr. Anne Ephrussi, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位: